Unicycive Therapeutics, Inc.

Unicycive Therapeutics is a biopharma company with development programs focused on two kidney diseases with largely unmet medical needs. 

Nasdaq: UNCY
IR Website: https://ir.unicycive.com/
Headquarters: Los Altos, CA

It is developing Renazorb* (lanthanum dioxycarbonate) an investigational phosphate binding agent using proprietary nanoparticle technology for the treatment of patients with hyperphosphatemia. They are also developing UNI-494, a novel new chemical entity that targets mitochondrial dysfunction which is in late preclinical development for the treatment of acute kidney injury.

BioRestorative Therapies, Inc.

BioRestorative Therapies is an emerging growth biopharma company focused on the research, development and commercialization of cellular therapies. 

Nasdaq: BRTX
IR Website: https://www.biorestorative.com/ir/
Headquarters: Melville, NY

The company's first platform technology is focused on musculoskeletal health; it is developing an indication using an autologous cell based therapeutic product to address chronic degenerative disc disease and has received approval from the FDA to initiate a Phase 2 clinical trial. Its second platform technology addresses metabolic disease through an allogeneic cell based therapeutic product derived from Brown Fat Tissue and has indications in obesity, Type 2 Diabetes, and PCOS amongst other metabolic diseases.  The Company has a robust pipeline of indications that will be leveraged across its two primary platform technologies. 

Avalon GloboCare Corp.

Avalon GloboCare Corp. (Nasdaq: ALBT) is a clinical-stage biotechnology company dedicated to develop and deliver innovative and transformative CellTech with multifunctional convergence in cellular technologies/therapeutics, precision diagnostics and intellectual property in the field of immuno-oncology and cellular medicines.

Nasdaq: ALBT
IR Website: https://ir.avalon-globocare.com/
Headquarters: Freehold, NJ

The company’s core technology platforms include cellular therapies (CAR-T, CAR-NK, mRNA-based Flash-CARTM), Avalon clinical-grade tissue-specific exosomes (ACTEXTM), and precision companion diagnostics related to cellular medicines.

First Wave BioPharma, Inc.

First Wave BioPharma is a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The Company is currently advancing a therapeutic development pipeline with multiple clinical stage programs built around its two proprietary technologies – the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients, and niclosamide, an oral small molecule with anti-inflammatory properties. First Wave is advancing two Phase 2 clinical programs built around adrulipase for the treatment of exocrine pancreatic insufficiency (FW-EPI) in patients with cystic fibrosis (CF) and chronic pancreatitis (CP). In developing adrulipase, First Wave is seeking to provide CF and CP patients with a safe and effective therapy to control EPI that is non-animal derived and offers the potential to dramatically reduce their daily pill burden. The company is also advancing multiple programs involving niclosamide, including FW-UP for ulcerative proctitis and ulcerative proctosigmoiditis, FW-UC for ulcerative colitis, and FW-CD for Crohn’s disease. First Wave BioPharma is headquartered in Boca Raton, Florida. For more information visit www.firstwavebio.com.

Nasdaq: FWBI
IR Website: https://firstwavebio.com/investors/overview
Headquarters: Boca Raton, FL

Clearfield, Inc.

Clearfield, Inc. (NASDAQ: CLFD) designs, manufactures, and distributes fiber optic management, protection, and delivery products for communications networks. Our “fiber to anywhere” platform serves the unique requirements of leading incumbent local exchange carriers (traditional carriers), competitive local exchange carriers (alternative carriers), and MSO/cable TV companies, while also catering to the broadband needs of the utility/municipality, enterprise, data center, and military markets. Headquartered in Minneapolis, MN, Clearfield deploys more than a million fiber ports each year. For more information, visit www.SeeClearfield.com.

Bragg Gaming Group

Bragg Gaming Group (NASDAQ: BRAG, TSX: BRAG) is a content-driven iGaming technology provider, serving online and land-based gaming operators with its proprietary and exclusive content, and its cutting-edge technology. 

Bragg Studios offer high-performing, data-driven and passionately crafted casino gaming titles from in-house brands Wild Streak Gaming, Spin Games, Atomic Slot Lab, Indigo Magic and Oryx Gaming. Its proprietary content portfolio is complemented by a range of exclusive titles from carefully selected studio partners which are Powered By Bragg: games built on Bragg remote games server (Bragg RGS) technology, distributed via the Bragg Hub content delivery platform and available exclusively to Bragg’s customers. 

Bragg’s modern and flexible omnichannel Player Account Management (Bragg PAM) platform powers multiple leading iCasino and sportsbook brands and is supported by expert in-house managed operational and marketing services. All content delivered via the Bragg Hub, whether exclusive or from Bragg’s large, aggregated games portfolio, is managed from a single back-office and is supported by powerful data analytics tools, as well as Bragg’s Fuze™ player engagement toolset. 

Bragg is licensed or otherwise certified, approved and operational in multiple regulated iCasino markets globally, including in New Jersey, Pennsylvania, Michigan, Ontario, the United Kingdom, the Netherlands, Germany, Sweden, Spain, Malta and Colombia.

Find out more here: https://bragg.group.

Genenta

Genenta (Nasdaq: GNTA) www.genenta.com is a clinical stage immuno-oncology company developing a cell-based platform harnessing the power of hematopoietic stem cells to provide durable and safe treatments for solid tumors.

Our platform is not tumor type nor target antigen restricted and provides sustained targeted expression of therapeutic payload(s) inside the tumor micro environment.

Genenta’s lead product candidate, Temferon™, precisely targets the delivery of interferon-alpha to the tumor micro-environment, minimizing systemic toxicity while breaking tumor-induced immune tolerance. Our treatments are designed as one-time monotherapies, but with the additional potential, when used in combination, to significantly enhance the efficacy of other approved therapeutics.

American Vanguard Corporation

Direct Digital Holdings

GigaCloud Technology Inc.

GigaCloud Technology Inc. offers a meticulously developed, technology-driven business-to-business platform coupled with a complete storage and fulfillment solution that serves large parcel retailers and eCommerce players around the world.

The platform, known as the “GigaCloud B2B Marketplace,” integrates everything from product discovery, payments, and messaging portals, leveraging channel diversification for suppliers, while resellers gain access to thousands of products backed by a complete logistics package.

Fortress Biotech, Inc.

Fortress Biotech, Inc. (“Fortress”) is an innovative biopharmaceutical company focused on acquiring, developing and commercializing high-potential marketed and development-stage drugs and drug candidates. The company has eight marketed prescription pharmaceutical products and over 30 programs in development at Fortress, at its majority-owned and majority-controlled partners and subsidiaries and at partners and subsidiaries it founded and in which it holds significant minority ownership positions. Such product candidates span six large-market areas, including oncology, rare diseases and gene therapy, which allow it to create value for shareholders. Fortress advances its diversified pipeline through a streamlined operating structure that fosters efficient drug development. The Fortress model is driven by a world-class business development team that is focused on leveraging its significant biopharmaceutical industry expertise to further expand the company’s portfolio of product opportunities. Fortress has established partnerships with some of the world’s leading academic research institutions and biopharmaceutical companies to maximize each opportunity to its full potential, including AstraZeneca plc, City of Hope, Fred Hutchinson Cancer Center, St. Jude Children’s Research Hospital, Nationwide Children’s Hospital and Sentynl Therapeutics, Inc. For more information, visit www.fortressbiotech.com.

Clene Inc.

Clene is a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative disease by targeting energetic failure, an underlying cause of many neurological diseases. The company is based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland. 

Neurodegenerative diseases present unique challenges that must be addressed in novel ways. Decades of research in neurology and the neuroscience fields have shown that many neurodegenerative diseases share a common underlying mechanism: a decline in the cell’s ability to produce energy.  Clene’s revolutionary nanotherapeutics have unleashed the extraordinary catalytic activity of elemental nanocrystals to improve cellular energy production in the setting of disease-related stress resulting in neuroprotection, neurorepair, and remyelination. In this way, nanotherapeutics may have broad applicability to disease states for which energy depletion or dysfunction are fundamental.

Our nanotherapeutics are produced utilizing a patented electro-crystal-chemistry process that results in highly-faceted, clean-surfaced nanocrystals of pure transition elements. This process is optimized to control three critical characteristics: size, shape (highly faceted crystal structure) and surfaces (contaminant free) to ensure consistently high catalytic activity for enhanced therapeutic benefit.

Our lead asset, CNM-Au8®, is potentially a first-in-class, orally-delivered, aqueous suspension of catalytically active, gold nanocrystals that improve cellular energy production and utilization.  We are currently investigating the clinical potential of CNM-Au8® for the treatment of Amyotrophic Lateral Scierosis (“ALS”), Multiple Scierosis (“MS”) and Parkinson’s Disease (“PD”).

Sunnova Energy International Inc.

Sunnova Energy International Inc. (NYSE: NOVA) is one of the leading Energy as a Service (EaaS) providers with customers across the U.S. and its territories. Sunnova's goal is to be the source of clean, affordable and reliable energy with a simple mission: to power energy independence so that homeowners have the freedom to live life uninterrupted®. For more information, please visit sunnova.com.

urban-gro, Inc.

urban-gro, Inc.® (Nasdaq: UGRO) is an integrated professional services and design-build firm. We offer value-added architectural, engineering, and construction management solutions to the Controlled Environment Agriculture (“CEA”), industrial, healthcare, and other commercial sectors. Innovation, collaboration, and creativity drive our team to provide exceptional customer experiences. With offices across North American and in Europe, we deliver Your Vision – Built. Learn more by visiting urban-gro.com.

TAG Oil Ltd.

TAG Oil (TSXV: TAO, OTCQX: TAOIF) is a Canadian-based and listed oil and gas exploration company pursuing acquisitions, exploration, and production in the Middle East and North African (MENA) region.

Our forward-looking strategy is to position the Company for significant growth via strategic acquisition, property development, enhanced production methods, and capitalizing on overlooked opportunities. TAG Oil's leadership team has demonstrated success implementing these strategies in the past, and looks to the future to build new, significant shareholder value.

TAG has the first piece of its MENA-based strategic acquisition plan into place with its first petroleum services agreement in the Badr Oil Field (BED-1), Western Desert, Egypt that potentially holds more than 500 million barrels of oil in place, and to date, the ARF zone has never been developed in Egypt.

The Company also continues to receive production royalties in New Zealand, and maintains a solid balance sheet.

Stitch Fix

Stitch Fix combines the human touch of expert stylists with the precision of advanced data science to make online personal styling accessible to everyone. Stitch Fix helps millions of clients across the United States and United Kingdom find clothing and accessories they love through a unique model that can extend far beyond the closet to define the future of shopping. For more, visit https://www.stitchfix.com. 

Cingulate Inc.

Cingulate Inc. (NASDAQ: CING), is a biopharmaceutical company utilizing its proprietary PTR™ drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. With an initial focus on the treatment of ADHD, Cingulate is identifying and evaluating additional therapeutic areas where PTR technology may be employed to develop future product candidates, including to treat anxiety disorders. Cingulate is headquartered in Kansas City. For more information visit Cingulate.com.

Getaround, Inc.

Offering a 100% digital experience, Getaround makes sharing cars and trucks simple through its proprietary cloud and in-car Connect® technology. The company's mission is to empower people to carshare everywhere and shift away from car ownership through instant and convenient access to desirable, affordable, and safe cars from entrepreneurial hosts. Getaround’s on-demand technology enables a contactless experience — no waiting in line at a car rental facility, manually completing paperwork, or meeting anyone to collect or drop off car keys. Getaround aims to utilize its peer-to-peer marketplace to help solve some of the most pressing challenges facing the world today, including environmental sustainability and access to economic opportunity. Launched in 2011, Getaround is available today in more than 1,000 cities across the United States and Europe. For more information, please visit https://www.getaround.com/.

Ocugen, Inc.

Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. 

Nasdaq: OCGN
IR Website: https://ir.ocugen.com/
Headquarters: Malvern, PA

We are making an impact on patient’s lives through courageous innovation—forging new scientific paths that harness our unique intellectual and human capital. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with a single product, and we are advancing research in infectious diseases to support public health and orthopedic diseases to address unmet medical needs. Discover more at www.ocugen.com and follow us on Twitter and LinkedIn.

Powerfleet

Powerfleet (NASDAQ: PWFL; TASE: PWFL) is a global leader of internet of things (IoT) software-as-a-service (SaaS) solutions that optimize the performance of mobile assets and resources to unify business operations. Our data science insights and advanced modular software solutions help drive digital transformation through our customers’ and partners’ ecosystems to help save lives, time, and money. We help connect companies, enabling customers and their customers to realize more effective strategies and results. Powerfleet’s tenured and talented team is at the heart of our approach to partnership and tangible success. The company is headquartered in Woodcliff Lake, New Jersey, with our Pointer Innovation Center (PIC) in Israel and field offices around the globe. For more information, please visit www.powerfleet.com.

Arbe Robotics

Arbe is leading a radar revolution, providing 4D Imaging Radar solutions that enable truly safe driver-assist systems today, while paving the way for fully autonomous driving. Arbe is empowering the automotive market, enabling vehicles with next-generation sensing and paradigm-changing perception.

Arbe's Imaging Radar offers an order of magnitude higher resolution than any other competing radar solution in the market, and is an essential sensor for L2+ and higher levels of autonomy. Arbe's solution includes an RF chipset with the largest channel array in the industry, a groundbreaking radar processor chip, and AI-based post-processing. Founded in 2015, Arbe has offices in Israel and the United States.

Ur-Energy

Ur-Energy (TSX: URE; NYSE American: URG) owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming which has produced ~2.7 million pounds of U₃O₈ since beginning production in 2013. In December 2022, Ur-Energy announced the signing of 600,000 pounds of annual, long-term off-take agreements and its intention to ramp up production. In 2021, Lost Creek received an amendment to its license allowing expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project. The license now allows annual plant production up to 2.2 million pounds U₃O₈, which includes wellfield production of up to 1.2 million pounds U₃O₈ and toll processing of up to one million pounds U₃O₈. Additional approvals for this expansion are expected in 2023. Our second uranium in-situ recovery facility, Shirley Basin Project, has received all major authorizations and is construction ready.

Nayax

Nayax (Nasdaq & TASE: NYAX) is a global commerce enablement and payment platform designed to improve retailers' revenue and operational efficiency. Nayax offers a complete solution including localized cashless payment acceptance, a management suite, and consumer engagement tools, enabling merchants to conduct commerce anytime, anywhere. With global experience in serving the unattended retail industry, Nayax has transformed into a comprehensive solution focused on our customers' growth across multiple verticals. Today, Nayax’s worldwide influence is reflected in its listing on both the Tel Aviv Stock Exchange (TASE) and on Nasdaq, and its 9 global offices with 800 employees. Nayax has connections to more than 80 merchant acquirers and payment method integrations and is a recognized payment facilitator worldwide. Nayax's vision is to redefine commerce to benefit communities around the world. Please visit www.nayax.com to learn more.

Local Bounti Corporation

Local Bounti Corporation (NYSE: LOCL, LOCL WS), is changing how food is grown and delivered to kitchen tables by utilizing patent-pending Stack Flow Technology™ to locally grow a variety of fresh, delicious, and sustainable products 365 days a year and distribute nationally with the largest distribution footprint in the controlled environment agriculture industry. The company operates advanced indoor facilities with its two brands: Local Bounti® and Pete's®, reducing the food miles required to ship to consumers across the United States. Our team is delivering on Local Bounti's promise to increase produce shelf life, reduce waste, conserve water, address scarcity in local communities, and lower GHG emissions. To find out more, visit localbounti.com or eatpetes.com, or follow Local Bounti on LinkedIn for the latest news and developments.

Farmland Partners Inc.

Farmland Partners Inc. is an internally managed, publicly traded (NYSE: FPI) real estate company that acquires high-quality, income-producing farmland throughout North America. The Denver-based company owns and/or manages approximately 195,000 acres of farmland in 19 states, making it the nation’s biggest farmland Real Estate Investment Trust (REIT) by acreage. 

Real Good Foods

Founded in 2016, Real Good Foods is on a mission to make nutritious foods more accessible and
improve human health. Real Good Foods is one of the only brands in frozen today to offer foods that are high in protein, lower in carbs and using real food ingredients—always grain free and gluten free.
Available in over 15,000 stores nationwide, and directly from their website at realgoodfoods.com. Learn more about Real Good Foods on Instagram @realgoodfoods, where they have one of the largest social media followings of any brand within the frozen food industry today with over 425,000 followers.

Lightwave Logic

Lightwave Logic, Inc. (Nasdaq: LWLG) is developing a platform leveraging its proprietary engineered electro-optic (EO) polymers to transmit data at higher speeds with less power. The Company’s high-activity and high-stability organic polymers allow Lightwave Logic to create next-generation photonic EO devices, which convert data from electrical signals into optical signals, for applications in data communications and telecommunications markets.

Solar Integrated Roofing Corp.

Solar Integrated Roofing Corp. (OTC: SIRC), is an integrated, single-source solutions provider of solar power, roofing and EV charging systems, specializing in commercial and residential properties throughout North America. The Company serves communities by delivering the best experience through constant innovation & legacy-focused leadership.

Aquabounty Technologies, Inc.

At AquaBounty Technologies, Inc. (NASDAQ: AQB), we believe we are a leader in land-based aquaculture leveraging decades of technology expertise to deliver disruptive solutions that address food insecurity and climate change issues. We are committed to feeding the world efficiently, sustainably and profitably. AquaBounty provides fresh Atlantic salmon to nearby markets by raising its fish in carefully monitored land-based fish farms through a safe, secure and sustainable process. The Company’s land-based Recirculating Aquaculture System (“RAS”) farms, located in Indiana, United States and Prince Edward Island, Canada, are close to key consumption markets and are designed to prevent disease and to include multiple levels of fish containment to protect wild fish populations. AquaBounty is raising nutritious salmon that is free of antibiotics and contaminants and provides a solution resulting in a reduced carbon footprint and no risk of pollution to marine ecosystems as compared to traditional sea-cage farming. For more information on AquaBounty, please visit www.aquabounty.com or follow us on Facebook, Twitter, LinkedIn and Instagram.

MamaMancini’s

MamaMancini’s Holdings, Inc. is a leading marketer and manufacturer of prepared foods with over 45,000 product placements in grocery, mass, club and convenience stores nationally.

The Company’s broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high quality, fresh, clean and easy to prepare foods to address the needs of both our consumers and retailers. Our vision is to become a one-stop-shop deli solutions platform, leveraging vertical integration and a diverse family of brands to offer a wide array of prepared foods to meet the changing demands of the modern consumer.

Lavoro

Founded by Dave Friedberg, The Production Board is a venture foundry and investment holding company working to solve the most fundamental problems on Earth by reimagining global systems of production across food, agriculture, biomanufacturing, human health, and the broader life sciences. TPB builds businesses based on emerging scientific discoveries, partners with exceptional talent, and provides them with the capital, infrastructure and market insights needed to deliver meaningful improvement in the cost, energy, time, or carbon footprint of conventional systems. Portfolio businesses include Supergut, Cana, Triplebar, Pattern Ag and many more. 

TPB is backed by leading strategic and financial investors, including Alphabet, Allen & Company LLC, Cascade, and funds and accounts managed by BlackRock, Baillie Gifford, Koch Disruptive Technologies, Counterpoint Global (Morgan Stanley), Foxhaven Asset Management, and Arrowmark Partners. TPB announced a $300 million investment in 2021 from leading financial and strategic institutions to deliver on its mission to “Reimagine Earth.”

Learn about TPB and our world-class team here.

NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd. (Nasdaq: NLSP) is a global development-stage biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists, focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system, or CNS, disorders, who have unmet medical needs. Headquartered in Switzerland and founded in 2015, NLS is led by an experienced management team with a track record of developing and commercializing product candidates.  For more information, please visit www.nlspharma.com.

Tritium DCFC Limited

Founded in 2001, Tritium (NASDAQ: DCFC) designs and manufactures proprietary hardware and software to create advanced and reliable DC fast chargers for electric vehicles. Tritium's compact and robust chargers are designed to look great on Main Street and thrive in harsh conditions, through technology engineered to be easy to install, own, and use. Tritium is focused on continuous innovation in support of our customers around the world.

For more information, visit tritiumcharging.com

Virax Biolabs

Virax Biolabs is an innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. At Virax Biolabs we believe we are developing a game-changing immunology platform based around our proprietary T-Cell testing technology, which is expected to be particularly effective in predicting the adaptive immune response to COVID-19, Hepatitis B, Epstein-Barr virus, Human Papilloma Virus, and other viral threats. ViraxClear test kits complement the anticipated Virax Immune T-Cell immunology platform via distribution networks.

Xybion Digital

Xybion Digital is a global software-as-a-service (SaaS) company providing life sciences and health systems companies with innovative software solutions to accelerate the transformation of today’s inventions into tomorrow’s approved medicines, devices, and diagnostic tests designed to save lives and keep employees safe. Our proven solutions help digitize drug research and development, laboratory testing, regulatory approvals, and pharmaceutical manufacturing on a single, unified cloud platform that is cost-effective, ready to deploy, and easy to use.

Our expansive software modules are seamlessly connected, creating a robust, unified laboratory execution system that provides a streamlined experience for all laboratory staff and a simplified, user-friendly IT environment. Our SaaS solutions address the holistic needs of regulated lab management with Preclinical LIMS, Cell & Gene Therapy LIMS, QC LIMS, Diagnostics LIMS, Quality Management System, Risk Prediction, Regulated Enterprise Document Management System, Employee Health, Workers’ Compensation, Workforce Safety, and Incident Management System in a comprehensive, all-in-one platform. We also provide consulting services to facilitate digital transformation of our client’s operating processes through Design Thinking, Process & System Rationalization, Computer Systems Validation, Data Management, Business Analysis and Project Management. Xybion Digital is the recipient of the Outstanding Service Award from the FDA’s National Center for Toxicological Research.

Xybion has over 160 clients in 29 countries using its low-code software to accelerate speed of innovation, improve compliance, expand capacity, minimize operating risks.

Tigo Energy

Tigo Energy, the worldwide leader in Flex MLPE (Module Level Power Electronics), designs innovative solar power conversion and storage products that provide customers more choice and flexibility. The Tigo TS4 platform increases solar production, decreases operating costs, and enhances safety. When combined with the Tigo Energy Intelligence (EI) platform, it delivers module, system, and fleet-level insights to maximize solar performance and minimize operating costs. The Tigo EI Residential Solar Solution, a flexible solar-plus-storage solution for home installations, rounds out the Company’s portfolio of solar energy technology. Tigo was founded in Silicon Valley in 2007 to accelerate the adoption of solar energy, and its global team supports customers whose systems reliably produce gigawatt hours of safe solar energy on seven continents.

MAG Silver Corp.

MAG Silver Corp. is a Canadian development and exploration company focused on becoming a top-tier primary silver mining company by exploring and advancing high-grade, district scale, silver-dominant projects in the Americas. Its principal focus and asset is the Juanicipio Project (44%), being developed with Fresnillo Plc (56%), the operator. The project is located in the Fresnillo Silver Trend in Mexico, the world's premier silver mining camp, where the operator is currently developing an underground mine and constructing a 4,000 tonnes per day processing plant. Underground mine production of mineralized development material commenced in Q3 2020, and an expanded exploration program is in place targeting multiple highly prospective targets at Juanicipio. MAG is also executing a multi-phase exploration program at the Deer Trail 100% earn-in project in Utah, and has recently acquired the Larder project located in the historically prolific Abitibi region of Canada.

Propel Holdings

Propel (TSX: PRL) is an innovative financial technology (“fintech”) company, committed to credit inclusion by facilitating fair, fast and transparent access to credit through its proprietary, industry-leading online lending platform. Understanding the challenge faced by millions of people without adequate access to credit, Propel, through its operating brands, is dedicated to bringing appropriate credit solutions to consumers in Canada and the United States. For more than a decade, Propel has leveraged its expertise in consumer lending, its robust capabilities in artificial intelligence and underwriting, and its steadfast dedication to a superior customer experience to facilitate approximately one million loans and lines of credit to consumers in need. For more information, please visit propelholdings.com.

Kolibri Global Energy Inc.

Kolibri Global Energy Inc. is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. Through various subsidiaries, the Company owns and operates energy properties in the United States. The Company continues to utilize its technical and operational expertise to identify and acquire additional projects. The Company's shares are traded on the Toronto Stock Exchange under the stock symbol KEI and on the OTCQX under the stock symbol KGEIF.

Koilibri has been one of the best growth stories of 2022, exiting the year over 4000boepd on a forecast of 2700 boepd. KEI is operating in Oklahoma, drilling the Caney Shale. Their outperformance has been a result of their continued improvement in drilling and their latest generation of their new completion technique on the five wells drilled last year, which outperformed their type curve by more than 40%. They have 55 more proven locations to drill, with drilling expected to restart around March 1st.

The company has been underfollowed from a research perspective and is trading at a discount to their 1 P NPV 10 value of US$10.07/share. The Company is expecting further production and reserve growth for 2023.

Rose Health

Precise Behavioral digitally powered by Rose: Smarter Mental Health

Healthcare company focused on the integration of behavioral healthcare into physical health care to improve patient health, improve measurable outcomes, and reduce the cost of care. Through our advanced technology, early identification, and human connection, we help behavioral health patients with connection, direction, care, and recovery.

ZyVersa Therapeutics, Inc.

ZyVersa (Nasdaq: ZVSA) is a clinical stage specialty biopharmaceutical company leveraging advanced, proprietary technologies to develop first-in-class drugs for underserved patients with renal and inflammatory diseases. The Company is currently advancing a therapeutic development pipeline with multiple programs built around its two proprietary technologies – VAR 200, a cholesterol efflux mediator for treatment of kidney diseases, and IC 100, a novel inflammasome ASC inhibitor to control damaging inflammation associated with numerous CNS and other inflammatory diseases. – For more information, please visit www.zyversa.com.

Xponential Fitness, Inc.

Xponential Fitness, Inc. (NYSE: XPOF) is the largest global franchisor of boutique fitness brands. Through its mission to make boutique fitness accessible to everyone, the Company operates a diversified platform of ten brands spanning across verticals including Pilates, indoor cycling, barre, stretching, rowing, dancing, boxing, running, functional training and yoga. In partnership with its franchisees, Xponential Fitness offers energetic, accessible, and personalized workout experiences led by highly qualified instructors in studio locations across 48 U.S. states and Canada, and through master franchise or international expansion agreements in 14 additional countries. Xponential Fitness' portfolio of brands includes Club Pilates, the largest Pilates brand in the United States; CycleBar, the largest indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, the largest franchised indoor rowing brand in the United States; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix, the largest franchised yoga brand in the United States; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements, and the largest Barre brand in the United States; STRIDE, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program.

CECO Environmental

CECO Environmental is a leading environmentally focused, diversified industrial company, serving the broad landscape of industrial air, industrial water, and energy transition markets globally, providing innovative solutions and application expertise. CECO helps companies grow their business with safe, clean, and more efficient solutions that help protect people, the environment and industrial equipment.

Nasdaq: CECO
IR Website: https://investors.cecoenviro.com/
Headquarters: Dallas, TX

CECO works to improve air and water quality, optimize emissions management, and increase energy efficiency for highly engineered applications in power generation, midstream and downstream hydrocarbon processing and transport, electric vehicle production, polysilicon fabrication, semiconductor and electronics, battery production and recycling, specialty metals and steel production, beverage can and water/wastewater treatment.  Additional information about CECO is available at www.cecoenviro.com.

Viad

Viad (NYSE: VVI), is a leading global provider of extraordinary experiences, including hospitality and leisure activities, experiential marketing, and live events through two businesses: Pursuit and GES. Our business strategy focuses on delivering extraordinary experiences for our teams, clients and guests, and significant and sustainable growth and above-market returns for our shareholders. Viad is an S&P SmallCap 600 company.

Pursuit is a collection of inspiring and unforgettable travel experiences in Alaska, Montana, the Canadian Rockies, Vancouver, Reykjavik, and Las Vegas, as well as new experiences planned in Chicago and Toronto. Pursuit’s collection includes attractions, lodges and hotels, and sightseeing tours that connect guests with iconic places.

GES is a global, full-service live events company offering a comprehensive range of services to the world's leading brands and event organizers through two reportable segments, Spiro and GES Exhibitions. Spiro is an experiential marketing agency that partners with leading brands around the world to manage and elevate their global experiential marketing activities. GES Exhibitions is a global exhibition services company that partners with leading exhibition and conference organizers as a full-service provider of strategic and logistics solutions to manage the complexity of their shows with teams throughout North America, Europe, and the Middle East.

NeuroOne Medical Technologies Corporation

G2 Goldfields Inc.

The G2 Goldfields team is comprised of professionals who have been directly responsible for the discovery of millions of ounces of gold in Guyana as well as the financing and development of the Aurora Gold Mine, Guyana’s largest gold mine.

In April 2022, G2 announced its maiden mineral resource estimate at the 19,200-acre Oko property, Guyana. The OKO district has been a prolific alluvial goldfield since its initial discovery in the 1870s. The estimate confirmed 974,000 oz inferred @ 9.25 g/t Au and 220,000 oz indicated @ 8.63 g/t Au. Significantly, the reported resources lie within 350 metres of surface and remain open down plunge. Since the maiden resource, G2 has reported an expansion to the strike of Shears 3, 4 and 5 having completed an additional 36 additional diamond drill holes for 13,279 metres in the Oko Main Area. G2’s OMZ drilling program has provided further confidence in the continuity of gold mineralization outlined in the resource estimate.

The Ghanie Zone is the second and most recent discovery made by G2 and lies between the Company’s OKO Main Zone (OMZ) and Reunion Gold’s Block 4 discovery. Diamond drilling has continued to intersect significant disseminated gold mineralization [including 50m @ 1.7 g/t Au, 26.6m @ 5.1 g/t Au & 32.1m @ 2.2 g/t Au], with the zone encountered over a strike length of 800 metres to date. Trenching has exposed extensive auriferous stockwork zones. The Ghanie Zone remains open to depth and along strike.

The latest discoveries indicate the potential to add additional near surface resources. G2 has initiated an aggressive drill program to further explore and delineate the Ghanie Zone, whilst actively developing additional drill targets within the district. Highly prospective target areas continue to be identified and mapped across the Company’s extensive land package.

The Company recently ranked 26th in the OTC Markets Group 2023 OTCQX Best 50.

D-Wave Quantum Inc. 

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, employee scheduling, and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is working with enterprise customers on real-world applications that address optimization problems today, while building the technologies that will enable new solutions tomorrow.

Vista Outdoor Operations LLC

Vista Outdoor is the parent company of 41 renowned brands that design, manufacture and market sporting and outdoor products.

We serve a broad and diverse range of consumers around the globe, including outdoor enthusiasts, golfers, cyclists, backyard grillers, campers, hunters, recreational shooters, athletes, as well as law enforcement and military professionals.

At Vista Outdoor we are uplifted by our employees and their spirit of dedication, conservation and innovation. Our consumers, people and love of the outdoors drive us forward in our mission to bring the world outside so that we can bring them closer together.

Gambling.com Group Limited

Gambling.com Group Limited (Nasdaq: GAMB) is a multi-award-winning performance marketing company and a leading provider of digital marketing services active in the online gambling industry. Founded in 2006, the Group has offices globally, primarily operating in the United States and Ireland. Through its proprietary technology platform, the Group publishes a portfolio of premier branded websites including Gambling.com, Bookies.com and RotoWire.com.

Gambling.com Group is a media company and does not offer actual gambling services – rather, it helps online sportsbooks and casino operators acquire players. The Group owns and operates more than 50 websites in seven languages across 15 national markets covering all aspects of the online gambling industry, including iGaming and sports betting, and the fantasy sports industry.

Amprius Technologies

Amprius Technologies is at the forefront of transforming electric mobility with its revolutionary silicon anode lithium-ion battery. Its commercially proven batteries deliver unmatched performance – ultra-high energy density, high power density, extreme fast-charge rate capability, wide operating temperature, and long cycle life – required for aviation, aerospace, defense, and electric vehicles (EV). The company’s corporate headquarters is in Fremont, California, where it maintains an R&D lab and a pilot manufacturing facility.

Gilat Satellite Networks Ltd.

Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT) is a leading global provider of satellite-based broadband communications.

With over 35 years of experience, we create and deliver deep technology solutions for satellite, ground and new space connectivity and provide comprehensive end-to-end solutions and services, powered by our innovative technology. We believe in the right of all people to be connected and are united in our resolution to provide communication solutions to all reaches of the world.

Delivering high value solutions, our portfolio is comprised of a cloud-based platform and high- performance satellite terminals designed to work in harmony with satellite constellations,

including Very High Throughput Satellites (VHTS) and Software-Defined Satellites (SDS) in multiple orbits; high performance Satellite On-the-Move (SOTM) antennas; and highly efficient, high-power Solid State Power Amplifiers (SSPA) and Block Upconverters (BUC). Gilat’s comprehensive solutions support multiple applications with a full portfolio of products to address key applications including broadband access, mobility, cellular backhaul, military, government, and enterprise, all while meeting the most stringent service level requirements. For more information, please visit: www.gilat.com

Dyadic International

Dyadic International (Nasdaq: DYAI) is a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable, and accessible biopharmaceutical products for human and animal health.

Dyadic’s primary area of focus is on applying its industrially proven fungus Thermothelomyces heterothallica to speed development, lower costs, and improve performance of biologic vaccines and drugs at flexible commercial scales for the human and animal health markets.

Additionally, Dyadic is further developing the Dapibus™ filamentous fungal based microbial protein production platform for the development and large-scale manufacture of low-cost proteins, metabolites, and other biologic products for use in non-pharmaceutical applications, such as food, nutrition, and wellness. 

Dyadic is leveraging its microbial platform technologies to enable collaborators to develop effective preventative and therapeutic treatments in developed and emerging countries.

To learn more about the Dyadic C1 Technology, please visit www.dyadic.com.

Asure Software

Asure (Nasdaq: ASUR) is a leading provider of Human Capital Management (“HCM”) software solutions. We help small and mid-sized companies grow by assisting them in building better teams with skills to stay compliant with ever-changing federal, state, and local tax jurisdictions and labor laws, and better allocate cash so they can spend their financial capital on growing their business rather than back-office overhead expenses. Asure’s Human Capital Management suite, named Asure HCM, includes cloud-based Payroll, Tax Services, and Time & Attendance software as well as human resources (“HR”) services ranging from HR projects to completely outsourcing payroll and HR staff. We also offer these products and services through our network of reseller partners. Visit us at asuresoftware.com.

EIR Biopharma, Inc.

EIR Biopharma, Inc. is an early-stage privately held biotech company developing therapeutics for the treatment of eye disease. We have partnered with the University of Miami’s Bascom Eye Institute for the treatment of glaucoma, and the Weill Cornell Medical College of Cornell University for the treatment of atrophic “dry” age-related macular degeneration. The founders have over 50 years of senior level management experience in the biotechnology, pharmaceutical and biopharma industries, and have helped to create publicly traded biopharma companies with peak market capitalizations exceeding $15 billion.

Vision Marine Technologies Inc.

Vision Marine Technologies Inc. (Nasdaq: VMAR), strives to be a guiding force for change and an ongoing driving factor in fighting the problems associated with waterway pollution by disrupting the traditional boating industry with electric power, in turn directly contributing to zero pollution, zero emission and a noiseless environment. Our Flagship E-Motion™ 180E electric marine powertrain is the first fully electric purpose-built outboard powertrain system that combines an advanced battery pack, inverter, and high efficiency motor with proprietary union assembly between the transmission and the electric motor design utilizing extensive control software. Our E-Motion™ and related technologies used in this powertrain system are uniquely designed to improve the efficiency of the outboard powertrain and, as a result, enhance both range and performance. Vision Marine continues to design, innovate, manufacture, and sell handcrafted, environmentally friendly, electric recreational boats to customers. The design and technology applied to our boats results in far greater enhanced performance in general, higher speeds, and longer range. Simply stated, a smoother ride than a traditional internal combustion engine (ICE) motorboat.

Ormat Technologies, Inc.

At Ormat Technologies, we are dedicated to providing 24/7 clean energy solutions worldwide. Our expertise lies in geothermal power, recovered energy, and energy storage, making us a leader in environmentally responsible power solutions. With over 55 years of experience and a global presence in over 30 countries, we design, build, and supply power-generating equipment for geothermal and recovered energy power plants. Our 1.1 GW portfolio comprises 1,070 MW of geothermal, Waste Heat and solar generation and 88 MW of energy storage, located in countries such as the U.S., Kenya, Guatemala, and more. Our vertically integrated structure allows us to utilize our expertise and experience to develop and deliver geothermal, recovered energy, and energy storage solutions. Join us in our mission to harness renewable energy.

Venus et Fleur

Venus et Fleur is a bespoke rose atelier that intersects the romantic tradition of sending flowers with exceptionally stylish design. We specialize in lush, customizable precision arrangements of real roses that maintain freshness for over a year. Each personal hand-delivery or shipment from Venus et Fleur arrives opulently encased in a Parisian-inspired keepsake hat box. The result is an elegant and thoroughly modern presentation that speaks to a highly discerning design aesthetic. Every arrangement is handcrafted by a floral design specialist, who meticulously curates only the most pristine roses for each order. Our team works closely with you to create a beautiful, bespoke arrangement according to your specifications. We love custom orders, and can integrate beautiful patterns, letters, and symbols with our roses available in an extensive color palette.

Journey Medical

Journey Medical (NASDAQ: DERM) is a commercial stage pharmaceutical company focused on acquiring and commercializing innovative dermatology products. Journey’s management team has over 175 years of collective experience commercializing some of the world’s most successful prescription dermatology brands. This experience has allowed us to identify undervalued assets and re-launch these assets through a best-in-dermatology sales and marketing organization. As a result, the company has grown revenue in each of the last 5 years, with a compounded annual growth of 42% over that period. Journey is also developing an oral rosacea drug (DFD-29) with sales potential exceeding $100mm annually. The drug is currently in Phase 3 clinical trials and demonstrated superior efficacy to the market leader in the Phase 2 study. For more information, visit www.journeymedicalcorp.com.

Adial Pharmaceuticals

Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions. The Company’s lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) in heavy drinking patients and was recently investigated in the Company’s ONWARD™ pivotal Phase 3 clinical trial for the potential treatment of AUD in subjects with certain target genotypes (estimated to be approximately one-third of the AUD population) identified using the Company’s companion diagnostic genetic test. ONWARD showed promising results in reducing heavy drinking in heavy drinking patients, and no overt safety or tolerability concerns. AD04 is also believed to have the potential to treat other addictive disorders such as Opioid Use Disorder, gambling, and obesity. Additional information is available at www.adial.com Twitter: @AdialPharma.

Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc. (NASDAQ: VVOS) is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as mild-to-moderate obstructive sleep apnea (OSA) and snoring in adults. The Vivos Method represents the first clinically effective nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution for treating mild to moderate OSA. It has proven effective in approximately 31,000 patients treated worldwide by more than 1,650 trained dentists.

The Vivos Method includes the Vivos Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and associated protocols that alter the size, shape and position of the soft tissues that comprise a patient’s upper airway and/or palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild-to-moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (VIP) program offers dentists training and other value-added services in connection with using The Vivos Method.

Bitfarms Ltd

Bitfarms Ltd is a global enterprise focused on decentralization and diversification to fuel the next generation in cryptocurrency mining. As the only publicly traded pure-play Bitcoin mining company audited by a Big Four audit firm, they are a global operation powered by entrepreneurial leaders and the most advanced technology available.

Nasdaq: BITF
Website: www.bitfarms.com
Headquarters: Toronto, Canada

The company’s mission is to secure the future economy of cryptocurrency for everyone through innovative, sustainable, and industrial-scale Bitcoin mining operations that engage communities around the world. Their operations and governance empower the digital financial economy with trust, transparency, and high industry standards.

Vertex Energy, Inc.

Vertex Energy, Inc. is a Houston-based energy transition company committed to providing decarbonized solutions and promoting energy security. Vertex owns a refinery in Mobile, AL, with an operational refining capacity of 75,000 barrels per day and 3.2 million barrels of product storage, making it a leading supplier of fuels in the region. Vertex is also one of the largest processors of used motor oil and co-products in the U.S. Gulf Coast, while its hydroprocessing and plant infrastructure in Belle Chasse, LA, presents high-yield, low-CAPEX opportunities for future energy transition projects. Vertex is currently working on a renewable diesel conversion project, with the anticipated completion expected to add an initial 8 to 10 thousand barrels per day of renewable fuels. Visit www.vertexenergy.com to learn more.

Verde AgriTech LTD

Verde is an agricultural technology company that produces potash fertilizers. Our purpose is to improve the health of all people and the planet. Rooting our solutions in nature, we make agriculture healthier, more productive, and profitable. 

Verde is a fully integrated Company: it mines and processes its main feedstock from its 100% owned mineral properties, then sells and distributes the Product. 

Verde’s focus on research and development has resulted in one patent and eight patents pending. Among its proprietary technologies are Cambridge Tech, 3D Alliance, MicroS Technology, N Keeper, and Bio Revolution.[1] Currently, the Company is fully licensed to produce up to 2.8 million tonnes per year of its multinutrient potassium fertilizers K Forte® and BAKS®, sold internationally as Super Greensand®. In 2022, it became Brazil's largest potash producer by capacity.[2] Verde has a combined measured and indicated mineral resource of 1.47 billion tonnes at 9.28% K₂O and an inferred mineral resource of 1.85 billion tonnes at 8.60% K₂O (using a 7.5% K₂O cut-off grade).[3] This amounts to 295.70 million tonnes of potash in K₂O. For context, in 2021 Brazil’s total consumption of potash in K₂O was 7.92 million[4]. 

Brazil ranks second in global potash demand and is its single largest importer, currently depending on external sources for over 96% of its potash needs. In 2021, potash accounted for approximately 2% of all Brazilian imports by dollar value.  

FiscalNote

FiscalNote is the leading technology provider of global policy and market intelligence. By uniquely combining AI technology, actionable data, and expert and peer insights, FiscalNote empowers customers with mission-critical insights and the tools to turn them into action.

We believe that leveraging technology is the key to providing transparency into the policy, people, and geopolitics shaping today’s world. Our technology sustains products and services that power clients around the world -- from small nonprofits to government agencies to large corporations (including more than half of the Fortune 100) -- with patented technology, expert analysis, and AI-powered data. Although our team and products have evolved significantly over time, we’ve never wavered from our north star to deliver novel, innovative, and compelling solutions to meet today’s most pressing challenges.

Home to CQ, FrontierView, Oxford Analytica, VoterVoice, and many other industry-leading brands, FiscalNote helps organizations stay ahead of rapidly evolving political, corporate, and regulatory environments.

Beam Global

Beam Global is a clean technology leader providing innovative, sustainable products and technologies for electric vehicle (EV) charging, energy storage, energy security and outdoor media. Based in San Diego and Chicago, Beam produces Made-in-America products with the mission to Lead the World to Clean Mobility. Beam is listed on Nasdaq under BEEM and BEEMW.

Nasdaq: BEEM, BEEMW
IR Website: https://beamforall.com/about/investor-relations/
Headquarters: San Diego, CA

Reviva Pharmaceuticals, Inc.

Reviva Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases.

Reviva’s pipeline currently has two drug candidates, brilaroxazine (RP5063) and RP1208. Both are new chemical entities discovered in-house using the Company’s proprietary chemical genomics driven technology platform.

The Company’s lead drug candidate, brilaroxazine, is in clinical development for multiple neuropsychiatric indications. These include schizophrenia, bipolar disorder, major depressive disorder (MDD), behavioral and psychotic symptoms in Alzheimer’s disease, Parkinson’s disease psychosis, and attention deficit hyperactivity disorder (ADHD). Reviva’s primary focus is to complete the clinical development of brilaroxazine for the treatment of acute and maintenance schizophrenia.

Volcon ePowersports, Inc.

Volcon builds industry-leading EV products that connect people to outdoor experiences through the intentional blending of technology and design. We believe in empowering adventure & play, the electric way! Visit our website for more information www.volcon.com

#EmpoweringAdventure

Riley Exploration Permian, Inc.

Riley Exploration Permian, Inc. (NYSE: REPX) is an independent oil and gas production company with operations focused on horizontal, development drilling of the conventional San Andres and Yeso Formations on the Northwest Shelf of the Permian Basin in West Texas. The company is led by a 3rd and 4th generation oilfield family with successful experience developing large acreage positions into sustainably profitable cashflow generation. Their contiguous acreage blocks are largely HBP (held by production) and their San Andres position is surrounded by the legacy Wasson Field and Brahaney Field, which have been undergoing secondary and tertiary recovery operations for decades. REPX is leveraging its proven operational excellence in the NW Shelf with the recent acquisition of its Yeso position.

Company Website: www.rileypermian.com/
Ticker: NYSE: REPX
Yahoo Finance URL: https:// finance.yahoo.com/quote/REPX?p-REPX

GeoVax Labs

GeoVax Labs is a clinical-stage biotechnology company developing novel therapies and vaccines for cancers and many of the world’s most threatening infectious diseases. The company’s lead program in oncology is a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, presently in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers, having received FDA Orphan Drug designation and the current clinical program being funded by the FDA Orphan Drugs Clinical Trials Program. GeoVax’s lead infectious disease program includes GEO-CM04S1, a next-generation Covid-19 vaccine targeting high-risk immunocompromised patient populations. Currently in two Phase 2 clinical trials, CM04S1 is being evaluated as a Covid-19 vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized Covid-19 vaccines are insufficient. In addition, CM04S1 is in a Phase 2 clinical trial evaluating the vaccine as a more robust, durable Covid-19 booster among healthy patients who previously received the mRNA vaccines. GeoVax has a solid financial foundation, is listed on Nasdaq (“GOVX”), with a leadership team who have driven significant value creation across multiple life science companies over the past several decades.

Splash Beverage Group, Inc.

Splash Beverage Group, Inc. offers investors all of the hallmarks of a premier small cap growth company, while ultimately delivering a margin profile on par with that of a world class beverage company. Splash has a strong management team and board of directors, both staffed with executives from RedBull, Diageo, Bacardi, Gallo, Sparkling Ice, Fuze, Muscle Milk, PepsiCo, Coca-Cola and Miller Coors. Splash’s mission is to continue to grow volume with its current portfolio, acquire exciting new brands, drive value through our global distribution network, capture supply chain efficiencies, and leverage our manufacturing and administrative infrastructure to a growing list of emerging brands.

Societal CDMO

Societal CDMO (NASDAQ: SCTL) is a bi-coastal contract development and manufacturing organization (CDMO) with capabilities spanning pre-Investigational New Drug (IND) development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms with a primary focus in the area of small molecules. With an expertise in solving complex manufacturing problems, Societal CDMO is a leading CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market.

In addition to our experience in handling DEA controlled substances and developing and manufacturing modified-release dosage forms, Societal CDMO has the expertise to deliver on our clients’ pharmaceutical development and manufacturing projects, regardless of complexity level. We do all of this in our best-in-class facilities, which total 145,000 square feet, in Gainesville, Georgia and San Diego, California.

Societal CDMO: Bringing Science to Society. For more information about Societal CDMO’s customer solutions, visit societalcdmo.com.

American Battery Technology Company

American Battery Technology Company provides a key source of domestically manufactured critical battery metals to help meet the near insatiable demand from the electric vehicle, electrical grid storage, and consumer electronics industries. The company’s ESG-principled focus works to create a closed-loop circular economy for battery metals with ethical and environmentally sustainable sourcing of critical and strategic materials. Through its three divisions, lithium-ion battery recycling, primary metal extraction technologies and primary resource development, the company is uniquely positioned to supply low-cost, low-environmental impact, and domestically sourced battery metals.